Target Pipelines

Subscribe to
our newsletters!

It may be used once or twice a day depending on the dog’s symptoms and the severity of the symptoms. However, the fda also recognized that antibiotics do not only prevent infections, but Mostovskoy also treat existing infections. Tamoxifen is a kind of estrogen that has to be given for a long period, about 10-12 years in the majority of cases.

Clomid is used to help regulate hormone levels in your body. The highest concentration of Sellye come acquistare viagra con pagamento postepay cephalexin monohydrate 500 mg dosage for this concentration means the lowest volume is. I have also researched on http://www.hometool.com/index.htm.

Showing 21–36 of 36 results

  • June of 2019
    This Target Pipeline List provides an overview of DLL3-targeted antibody and cell therapeutics in development for treatment of small cell lung cancer (SCLC).
     50.00
  • May of 2019
    This report provides an overview of CD33-targeted antibody and cell therapies in development for treatment of acute myeloid leukemia (AML)
     150.00
  • April of 2019
    This report provides an overview of small molecule inhibitors of Tyk2 in development for treatment of inflammatory diseases.
     125.00
  • April of 2019
    This report provides an overview of small molecule inhibitors of NLRP3 in development for treatment of chronic inflammatory diseases.
     75.00
  • April of 2019
    This report provides an overview of therapeutic antibodies against GM-CSF or its receptor in development for treatment of inflammatory diseases.
     50.00
  • March of 2020
    This report provides an overview of anti-FcRn therapeutic antibodies and proteins in development for treatment of IgG-mediated autoimmune diseases.
     100.00
  • April of 2019
    This report provides an overview of therapeutic proteins in development for treatment of arginine-dependent tumors or for enzyme replacement therapy.
     75.00
  • April of 2019
    This report provides an overview of CD40 agonistic antibodies, proteins or viral vectors in development for treatment of solid tumors as monotherapy or in combination therapy.
     150.00
  • March of 2019
    This Target Pipeline List provides an overview of biologic and chemical entities on the market or in development for treatment of hyperuricemia associated with gout or tumor lysis
     150.00
  • February of 2019
    This report provides an overview of isolated and recombinant asparaginase enzymes on the market or in development for treatment of leukemia and solid tumors.
     100.00
  • January of 2019
    This Target Pipeline List provides an overview of biologic and small molecule approaches to raise high density lipoprotein (HDL) for reduction of recurrent cardiovascular events.
     100.00
  • December of 2018
    This Target Pipeline List provides an overview of antibodies targeting interleukin-33 (IL-33) or its receptor ST2 (IL1RL1) in clinical development for treatment of atopic diseases.
     75.00
  • January of 2019
    This Target Pipeline List provides an overview of agonist antibodies and fusion proteins targeting death receptor 4 and/or 5 in development for treatment of cancer.
     100.00
  • January of 2019
    This Target Pipeline list provides an overview of antibody- and cell-based therapeutics targeting DLL3 in development for treatment of DLL3-overexpressing cancers.
     50.00
  • January of 2019
    This Target Pipeline List provides a pipeline overview of tau imaging agents in development for diagnosis of tauopathies and measurement of tau-targeted treatment effects
     50.00
  • January of 2019
    This Target Pipeline List provides a pipeline overview of EP4 receptor antagonists in development for treatment of cancer
     50.00